Skip to main content
. 2005 Aug 7;11(29):4519–4523. doi: 10.3748/wjg.v11.i29.4519

Table 2.

SOD activity and MDA content in BXPC-3 cells 3 d after IAA and HRP treatment (mean±SD)

Treatment Control 40 µmol/L 80 µmol/L
IAA /HRP IAA/HRP
SOD (nU/mg protein) 105.60±41.04 135.98±1.46 193.34±37.89b
MDA (µmol/L/mg protein) 20.80±0.33 22.29±1.04 99.53±30.45b

bP<0.01 control group vs treatment group.